دورية أكاديمية
أعرض في EDS

Procedural safety of transcatheter aortic valve replacement with Portico valve: a systematic review.

التفاصيل البيبلوغرافية
العنوان: Procedural safety of transcatheter aortic valve replacement with Portico valve: a systematic review.
المؤلفون: Jaiswal V; Division of Cardiovascular Research, Larkin Community Hospital, South Miami, Florida.; JCCR Cardiology Research, Varanasi, India., Wajid Z; Department of Internal Medicine, Wayne State University School of Medicine, Michigan., Suresh V; Department of Medicine, King George's Medical University, Lucknow., Hanif M; Department of Internal Medicine, SUNY Upstate Medical University, Syracuse, New York., Rajak K; Department of Internal Medicine, UPMC Harrisburg, Pennsylvania., Halder A; Department of Internal Medicine, UPMC Harrisburg, Pennsylvania., Endurance E; Internal Medicine Department, St. Luke's Hospital, St. Louis, Missouri., Aiwuyo H; Internal Medicine Department, St. Luke's Hospital, St. Louis, Missouri., Choudhari J; Division of Cardiovascular Research, Larkin Community Hospital, South Miami, Florida., Naz S; The University of Texas, MD Anderson Cancer Center, Texas., Ang SP; Department of Medicine, Bangalore Medical College and Research Institute, Karnataka., Shrestha AB; Department of Internal Medicine, M Abdur Rahim Medical College, Dinajpur, Bangladesh.
المصدر: International journal of surgery (London, England) [Int J Surg] 2023 Nov 01; Vol. 109 (11), pp. 3602-3608. Date of Electronic Publication: 2023 Nov 01.
نوع المنشور: Systematic Review; Journal Article
اللغة: English
بيانات الدورية: Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 101228232 Publication Model: Electronic Cited Medium: Internet ISSN: 1743-9159 (Electronic) Linking ISSN: 17439159 NLM ISO Abbreviation: Int J Surg Subsets: MEDLINE
أسماء مطبوعة: Publication: 2023- : [Philadelphia] : Wolters Kluwer Health, Inc.
Original Publication: London : Surgical Associates Ltd., c2004-
مواضيع طبية MeSH: Transcatheter Aortic Valve Replacement*/adverse effects , Transcatheter Aortic Valve Replacement*/methods , Aortic Valve Stenosis*/surgery , Heart Valve Prosthesis*/adverse effects, Humans ; Female ; Animals ; Swine ; Aged, 80 and over ; Male ; Aortic Valve/surgery ; Treatment Outcome ; Postoperative Complications/etiology ; Prosthesis Design
مستخلص: Background: The Portico transcatheter aortic heart valve is a self-expandable, fully resheathable bioprosthetic valve with a nitinol frame and porcine pericardial sealing cuff. It has been used among symptomatic severe aortic stenosis (AS) who are at high or extreme surgical risk. However, till date very few studies has been reported with inconclusive evidence for its postprocedure safety outcomes.
Objective: The authors aim to evaluate the safety of the Portico transcatheter aortic valve replacement system among patients with AS.
Methodology: The authors conducted a systematic literature search on PubMed, Embase, and Scopus from inception till 10th April 2023 by using predefined MESH terms using 'AND' and 'OR'. The following search terms were used: 'Aortic Stenosis' AND 'Transcatheter aortic valve replacement' OR 'Portico valve'. Finally, descriptive statistics were used to summarize the data in this paper. The mean and SD were adopted to describe continuous variables, whereas frequencies and percentages were used for dichotomous data.
Results: A total of 7 studies with 2782 patients were included in the analysis. The mean age of patients was 82.3 years, and 54.63% were female. The most common comorbidity was hypertension (65.21%) and diabetes mellitus (26.45%). Among patients of AS with Portico valve implants, postprocedural outcomes including 30-day mortality (2.32%), cardiovascular mortality (2.37%), stroke (2.23%), myocardial infarction (0.94%), major bleeding (3.97%), major vascular complications (4.91%), acute kidney injury (1.37%), and permanent pacemaker implantations in 15.73% patients were reported. Overall, device success was observed in 95.82% of patients.
Conclusion: Transcatheter aortic valve replacement with the repositionable Portico valve, a new bioprosthesis, appears to have a low postprocedural mortality rate and other clinical outcomes in high-risk patients with severe AS.
(Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc.)
References: Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. New Eng J Med 2010;363:1597–1607.
Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. New Eng J Med 2016;374:1609–1620.
Mollmann H, Linke A, Nombela-Franco L, et al. Procedural safety and device performance of the Portico TM valve from experienced TAVI centers: 30-day outcomes in the multicenter CONFIDENCE registry. J Clin Med 2022;11:4839.
Perlman GY, Cheung A, Dumont E, et al. Transcatheter aortic valve replacement with the Portico valve: one-year results of the early Canadian experience. EuroIntervention 2017;12:1653–1659.
Manoharan G, Linke A, Moellmann H, et al. Multicentre clinical study evaluating a novel resheathable annular functioning self-expanding transcatheter aortic valve system: safety and performance results at 30 days with the Portico system. EuroIntervention 2016;12:768–774.
Thourani VH, Kodali S, Makkar RR, et al. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet 2016;387:2218–2225.
Giulia Costa, Lars Søndergaard. Portico with FlexNav TAVI system: enhancing innovative technology to optimize patient outcomes and physician experience. Portico with FlexNav TAVI system: enhancing innovative technology to optimize patient outcomes and physician experience. Published May 5, 2020. Accessed 14 April 2023. https://www.pcronline.com/Cases-resources-images/Industry-partner-perspectives/Sponsored-content/2020/Portico-with-FlexNav-TAVI-system.
Blumenstein J, Eckel C, Husser O, et al. Multi-center comparison of two self-expanding transcatheter heart valves: a propensity matched analysis. J Clin Med 2022;11:4228.
Walther T, Manoharan G, Linke A, et al. Incidence of new-onset left bundle branch block and predictors of new permanent pacemaker following transcatheter aortic valve replacement with the Portico TM valve. Eur J Cardiothorac Surg 2018;54:467–474.
Jaiswal V, Hanif M, Ang SP, et al. Racial disparity between the post-procedural outcomes among patients with peripheral artery disease: a systematic review and meta-analysis. Curr Probl Cardiol 2023;48:101595.
Jaiswal V, Nepal G, Dijamco P, et al. Cerebral venous sinus thrombosis following covid-19 vaccination: a systematic review. J Prim Care Community Health 2022;13:21501319221074450.
Jaiswal V, Ang SP, Ishak A, et al. Comparison of outcome among type 2 vs type 1 myocardial infarction: a systematic review and meta-analysis. J Investig Med 2023;71:223–234.
Corcione N, Biondi-Zoccai G, Ferraro P, et al. Long-term follow-up of transcatheter aortic valve implantation with Portico versus evolut devices. Am J Cardiol 2020;125:1209–1215.
Willson AB, Rodès-Cabau J, Wood DA, et al. Transcatheter aortic valve replacement with the St. Jude Medical Portico valve: first-in-human experience. J Am Coll Cardiol 2012;60:581–586.
Möllmann H, Linke A, Holzhey DM, et al. Implantation and 30-Day follow-up on all 4 valve sizes within the portico transcatheter aortic bioprosthetic family. JACC Cardiovasc Interv 2017;10:1538–1547.
Linke A, Holzhey D, Möllmann H, et al. Treatment of aortic stenosis with a self-expanding, resheathable transcatheter valve: one-year results of the international multicenter portico transcatheter aortic valve implantation system study. Circ Cardiovasc Interv 2018;11:e005206.
Giordano A, Corcione N, Ferraro P, et al. Propensity-score-adjusted comparison of Evolut vs. Portico devices for transcatheter aortic valve implantation. J Cardiovasc Med (Hagerstown) 2019;20:351–357.
Giordano A, Corcione N, Ferraro P, et al. Comparative one-month safety and effectiveness of five leading new-generation devices for transcatheter aortic valve implantation. Sci Rep 2019;9:17098.
Del Trigo M, Dahou A, Webb JG, et al. Self-expanding Portico valve versus balloon-expandable SAPIEN XT valve in patients with small aortic annuli: comparison of hemodynamic performance. Rev Esp Cardiol (Engl Ed) 2016;69:501–508.
Tzikas A, Amrane H, Bedogni F, et al. Transcatheter aortic valve replacement using the portico system: 10 things to remember. J Interv Cardiol 2016;29:523–529.
Tzikas A, Chrissoheris M, Halapas A, Spargias K. PorticoTM transcatheter heart valve. Hellenic J Cardiol 2015;56 Suppl A:15–19.
Jared M, O’Leary FDA. Approves PORTICO with FlexNav TAVR System for Use in Severe Aortic Stenosis Patients at High or Extreme Risk for Surgical Aortic Valve Replacement | SCAI. Accessed 26 April 2023 https://scai.org/fda-approves-portico-flexnav-tavr-system-use-severe-aortic-stenosis-patients-high-or-extreme-risk.
Reardon MJ, Chehab B, Smith D, et al. 30-day clinical outcomes of a self-expanding transcatheter aortic valve: the international PORTICO NG study. JACC Cardiovasc Interv 2023;16:681–689.
Renker M, Kim WK. Choice of transcatheter heart valve: should we select the device according to each patient’s characteristics or should it be “one valve fits all”? Ann Transl Med 2020;8:961.
تواريخ الأحداث: Date Created: 20230815 Date Completed: 20231124 Latest Revision: 20231124
رمز التحديث: 20240829
مُعرف محوري في PubMed: PMC10651300
DOI: 10.1097/JS9.0000000000000645
PMID: 37581642
قاعدة البيانات: MEDLINE
الوصف
تدمد:1743-9159
DOI:10.1097/JS9.0000000000000645